Table 2 Reproducibility of the ASES index
Baseline | Change from first to second measurement | Reproducibility | |||||
|---|---|---|---|---|---|---|---|
Mean (SD) | Range | Floor* N (%) | Ceiling** N (%) | Mean (95% CI) [Effect Size] | ICC (95% CI) | CR (95% CI) | |
Pain score, all patients (N = 105) | 21.9 (14.1) | 0-50 | 5(5) | 3(3) | 4.0 (1.8 to 6.1) [0.26] | 0.66 (0.52 to 0.77) | 23 (19 to 28) |
Improved (N = 25) | 26.9 (14.4) | 0-48 | 2(8) | 0(0) | 5.8 (0.5 to 11.2) [0.42] | 0.50 (0.04 to 0.77) | 27 (19 to 38) |
Stable (N = 55) | 22.3 (14.7) | 0-50 | 2(4) | 3(5) | 3.9 (0.9 to 7.0) [0.27] | 0.68 (0.46 to 0.82) | 23 (17 to 29) |
Worsened (N = 25) | 15.9 (9.8) | 0-36 | 1(4) | 0(0) | 2.2 (-1.6 to 6.0) [0.19] | 0.67 (0.37 to 0.83) | 18 (14 to 23) |
Function score, all patients (N = 105) | 25.5 (11.5) | 2-50 | 0(0) | 1(1) | 0.2 (-1.3 to 1.6) [0.01] | 0.81 (0.71 to 0.88) | 14 (11 to 18) |
Improved (N = 25) | 27.5 (11.4) | 3-46 | 0(0) | 0(0) | 2.6 (-0.1 to 5.3)[0.23] | 0.81 (0.51 to 0.93) | 13 (8 to 20) |
Stable (N = 55) | 26.0 (11.3) | 3-50 | 0(0) | 1(2) | -1.5 (-3.4 to 0.4) [0.13] | 0.83 (0.64 to 0.92) | 14 (10 to 19) |
Worsened (N = 25) | 22.5 (12.1) | 1-40 | 0(0) | 0(0) | 1.5 (-1.9 to 4.9) [0.12] | 0.79 (0.57 to 0.90) | 16 (11 to 22) |
Total ASES, all patients (N = 105) | 47.4 (22.8) | 2-99 | 0(0) | 0(0) | 4.1 (1.4 to 6.9) [0.18] | 0.79 (0.69 to 0.86) | 29 (25 to 35) |
Improved (N = 25) | 54.5 (24.1) | 3-93 | 0(0) | 0(0) | 8.5 (1.5 to 13.4 )[0.37] | 0.69 (0.27 to 0.87) | 36 (24 to 52) |
Stable (N = 55) | 48.3 (22.8) | 7-99 | 0(0) | 0(0) | 2.4 (-1.2 to 5.9) [0.10] | 0.83 (0.70 to 0.90) | 26 (21 to 31) |
Worsened (N = 25) | 38.5 (19.2) | 2-73 | 0(0) | 0(0) | 3.7 (-2.1 to 9.4) [0.17] | 0.77 (0.59 to 0.87) | 28 (21 to 35) |